Gene Query: UGT8

Dataset Description Geneva Score
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 85.82
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 85.82
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 60.02
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 52.83
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 52.83
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 42.38
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 34.62
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 32.84
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 30.36
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 29.69
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 29.23
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 29.23
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 29.21
RNA sequencing of matched nephrectomy samples [RNA-seq] 29.21
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 28.84
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 28.84
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 27.33
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 26.28
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 24.42
Global epigenomic reconfiguration during mammalian brain development 24.41
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 23.42
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 23.37
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 23.37
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 23.36
WRN knockout effects upon gene expression in SW48 and OVK18 23.2
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 22.97
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 22.97
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 22.92
Dtx3L and Androgen Signaling in Prostate Cancer 21.64
Multiple sclerosis and EAE 21.39
Human optic chiasm from healthy controls and multiple sclerosis patients 21.39
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 21.34
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 21.03
Transcriptional profiling of LS1034 cells treated with tepoxalin 19.05
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 18.82
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 18.33
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 18.33
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 18.11
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 17.75
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 17.75
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 17.63
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 17.52
Gene expression analysis of the impact of TDP-43 knockout in human cells. 17.51
Next Generation Sequencing of human SMA and healthy control Motor Neurons 16.76
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 16.71
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 16.71
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 16.36
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 15.95
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 15.6
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 15.29
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 15.19
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 15.01
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 14.45
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 14.39
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 14.38
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 14.1
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 14.07
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 13.94
ChIP-seq and RNA-seq from human lymphoma cell lines 13.81
RNA-seq data from human lymphoma cell lines 13.81
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 13.53
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 13.08
T47D RNA-seq and ChrRNA-seq data 13.08
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 12.68
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 12.31
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 12.17
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 12.1
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 12.06
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 11.86
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 11.62
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 11.6
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 11.48
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 11.48
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 11.31
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 10.69
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 10.64
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 10.59
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 10.54
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 10.54
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 10.45
RNA expression following TMPRSS11B overexpression or depletion 10.39
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 10.34
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 10.16
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 10.12
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 9.85
RNA sequencing of BT142 and TS603 cell lines 9.85
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 9.66
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 9.37
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 9.37
RNA-seq analyses of human prostate cancer cells 9.34
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 9.18
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 9.15
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 9.11
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 9.11
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 9.1
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 9.0
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 8.92
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 8.92
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 8.74
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 8.69
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 8.66
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 8.64
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 8.63
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 8.55
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 8.52
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.47
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 8.47
Nutritional control of protein translation 8.37
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 8.36
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 8.34
A prostate cancer chromatin interaction map 8.31
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 8.27
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 8.21
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 8.06
Persistence of stem cell metabolism in cancers as a failure of differentiation 8.05
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 8.04
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 7.95
Landscape of H3K4me3 in human CD19 cells 7.93
RNA-seq of YB5 cells treated with Proscillaridin A 7.92
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 7.75
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 7.74
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 7.68
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 7.64
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 7.63
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 7.54
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 7.53
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 7.44
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 7.38
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 7.38
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 7.33
Transcriptome analysis of BAP1 knockout and restoration 7.33
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 7.29
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 7.29
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 7.19
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 7.18
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 7.17
RNA sequencing analysis of human embryonic stem cells and axial progenitors 7.11
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 7.02
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 7.0
Total RNA sequencing of APC mutant and wt colonic organoids 6.91
DIGIT regulates endoderm differentiation of human embryonic stem cells 6.91
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 6.88
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 6.83
Effect of disulfiram treatment on pediatric high grade glioma 6.8
Postnatal lipids drive hepatocyte maturation 6.77
The age and genomic integrity of neurons after cortical stroke in humans 6.76
Patient-derived luminal breast cancer xenografts with progestins 6.76
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 6.76
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 6.75
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 6.74
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 6.7
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 6.64
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 6.62
G-quadruplex structures mark human regulatory chromatin 6.57
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 6.55
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 6.46
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.44
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 6.44
Transcriptional responses of melanoma cells to BRAF inhibition 6.4
Proteomics identifies a marker signature of MAPKi resistance in melanoma 6.4
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 6.39
ARID1A regulates condensin II distribution and chromosomal partition 6.39
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 6.38
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 6.33
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 6.31
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.19
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.19
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 6.13
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 6.12
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.1
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.1
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 6.02
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.98
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 5.97
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 5.88
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 5.88
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 5.77
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 5.76
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 5.74
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 5.72
KLF6-dependent transcription in renal cancer cells 5.69
Identification of a LIF-responsive replication-competent human β cell 5.67
Transcriptomic analysis of LSD1 5.63
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 5.56
RNA-seq analysis of RALD iPSCs after in vitro differentiation 5.5
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 5.48
Transcriptome of EBV-infected gastric cancer cell lines 5.45
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 5.44
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 5.41
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 5.39
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 5.38
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 5.35
LncRNA-GAS5 negative regulation of YAP-target genes expression 5.35
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 5.34
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 5.34
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 5.34
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 5.33
TGF-β regulation of miRNA expression in pancreatic cancer 5.32
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 5.32
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 5.28
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 5.25
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 5.24
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 5.24
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 5.2
miR941 overexpression experiment 5.19
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 5.17
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.16
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.16
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 5.13
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.04
Epigenomic conservation of transposable element silencing [RNA-seq] 5.02
Epigenomic conservation of transposable element silencing 5.02
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 5.01
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 5.01
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 4.98
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 4.95
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 4.95
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 4.91
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 4.82
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 4.82
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.79
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 4.76
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 4.75
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 4.75
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 4.73
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.7
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 4.68
RNA-seq of RKO cells with cTAZ KO or putback 4.62
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 4.52
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 4.52
Global gene expression profile of dasatinib-resistant RCH-ACV cells 4.52
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 4.47
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 4.46
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 4.46
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 4.46
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 4.41
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 4.4
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 4.4
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 4.38
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 4.38
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 4.37
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 4.35
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 4.32
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.32
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 4.31
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 4.31
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 4.31
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.3
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 4.27
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 4.27
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 4.26
Human cell line and subcutaneous tumor 4.26
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 4.25
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 4.24
Global transcriptome analysis of WT versus HEB-/- hESCs 4.19
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.17
The MEF2B Regulatory Network 4.15
The MEF2B Regulatory Network - RNA-seq data 4.15
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 4.13
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 4.13
STX4 Over-Expression in Human islets 4.13
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 4.12
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 4.12
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 4.11
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 4.1
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 4.1
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 4.07
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 4.06
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.04
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 4.04
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 4.04
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 4.02
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 4.01
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 4.0
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 3.99
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 3.99
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.98
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.94
Transcriptomic analysis of ERR alpha orphan nuclear receptor 3.93
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 3.92
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 3.88
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 3.88
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 3.88
RNAseq in Alzheimer's Disease patients 3.87
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.86
Identification of long noncoding RNAs regulated by p53 3.83
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 3.83
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 3.82
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.8
Exploring the RNA landscape of endothelial exosomes 3.79
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 3.78
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 3.78
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 3.75
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 3.75
LINE-2 transposable elements are a source of functional human microRNAs and target sites 3.75
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 3.72
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 3.65
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 3.65
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.65
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 3.62
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 3.59
The effect of insulin on mRNA transcription of human pluripotent stem cells 3.57
Total RNA sequencing of WT intestinal orgaonids. 3.56
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.55
circRNA-sequencing 3.52
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.51
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 3.5
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 3.5
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 3.49
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 3.48
Universal alternative splicing of noncoding exons 3.48
High-efficiency RNA-based reprogramming of human primary fibroblasts 3.47
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 3.46
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.44
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.44
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.42
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.42
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.39
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 3.37
iPSC-Derived Cholangiocytes 3.37
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 3.35
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.35
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.27
Aortic Valve Tissue: Stenosis vs. Sclerosis 3.26
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 3.18
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 3.18
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 3.12
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 3.12
CUREfast: Accelerating research with families 3.12
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.1
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.09
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 3.08
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.04
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.02
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 3.0
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 3.0
RNA seq comparison between scrambled and shGRP78 cells 2.95
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.94
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 2.87
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.84
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.83
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.83
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.78
Gene expression alterations of pancreatic intraepithlial neoplasia 2.77
RNA-seq analysis of control and Myc-induced U2OS cells 2.75
NKX2.2 2.72
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 2.72
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.72
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.69
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 2.67
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 2.67
RNA-seq of SCLC PDX models treated with EP 2.66
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.63
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 2.57
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.54
Reassessment of Exosome Composition 2.52
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 2.49
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.47
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.47
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 2.47
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.45
Common inflammatory pathways between NEC and Crohn's disease 2.43
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.42
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 2.41
RNA seq analysis of human Fetal and adult derived Enterospheres 2.4
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 2.39
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.39
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 2.38
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 2.32
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.32
Transcriptome analysis of H9 hESC derived cerebral organoids 2.29
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 2.27
The role of the Calcium-Sensing receptor in colorectal cancer 2.1
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.1
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.03
Cell responses to dysregulated VZV-induced cell-cell fusion 2.0
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 1.99
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.98
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.95
Identification of expressed and conserved human non-coding RNAs 1.94
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.93
Gene expression analysis in response to hypoxic pathway inhibition 1.91
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 1.89
6mer seed toxicity in tumour suppressive microRNAs 1.87
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.86
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.85
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.84
Downregulation of LATS kinases alters p53 to promote cell migration 1.81
RNA-seq analysis of the human fetal kidney. 1.81
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.79
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.75
Direct Isolation and Characterization of Human Nephron Progenitors. 1.73
RNAseq of Breast cancer PDX samples 1.73
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 1.73
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.72
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.67
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.64
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.64
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.63
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.63
The Glioma-Infiltrating T Cell Receptor Repertoire 1.62
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 1.62
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 1.62
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 1.62
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 1.6
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 1.6
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.58
Repurposing of promoters and enhancers during mammalian evolution 1.56
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.54
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.54
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.53
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.45
Differential gene expression of human melanoma cells [RNA-seq] 1.43
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 1.43
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.42
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 1.41
Human neutrophil genome during PMA- and E. coli encounter-induced activation 1.41
The gene expression profiles of gallbladder cancer 1.34
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.33
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.28
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.28
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.28
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.23
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.17
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.16
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.16
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.12
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.12
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.08
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.05
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.04
Gene expression analysis of human adenomas. 1.01
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.01
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.0
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.0
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.99
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.98
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.97
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.94
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.93
Loss of endometrial plasticity in recurrent pregnancy loss 0.91
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.91
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.9
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.87
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 0.87
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.78
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.76
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.75
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.75
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.74
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.69
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.68
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.68
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.67
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.64
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.62
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.62
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.56
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.52
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.48
Human Tfh cell RNA bulk sequencing 0.46
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.43
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.39
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.36
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.36
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.36
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 0.36
RNA editing in nascent RNA affects pre-mRNA splicing 0.35
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.34
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.34
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.34
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.34
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.32
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.31
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.3
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.28
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.28
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.26
Changes in human endometrial gland transcriptome over the window of implantation 0.24
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.23
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.23
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.23
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.22
Gene expression analysis of breast cancer cell-lines 0.22
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.2
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.18
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 0.18
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.17
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.16
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.14
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.13
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.12
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.11
hNSCs siRNA NOVA2 0.07
RNA-seq of cancer cell lines treated with T-025 0.07
Gene expression of collecting duct carcinoma of the kidney 0.07
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.06
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.05
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.04
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation